Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Hetero Healthcare Limited
30 tablet
Tenofovir Alafenamide
Keep in cold place
Delivering To:
Overview
Tafero 25mg Tablet, comprising Tenofovir Alafenamide, is an antiviral medicine. It is prescribed for the treatment of HIV (Human Immunodeficiency Virus) infection and chronic Hepatitis B Virus (HBV) infection. It works to slow or stop the multiplication of the virus in the body and helps to clear the infection. It is advisable to take this medicine exactly as prescribed by the healthcare provider for better efficacy without increasing or decreasing the dose strength. This medicine is available at the best price in India.
HIV
Tafero 25mg Tablet is used in the treatment of:
Hepatitis B virus (HBV) infection
The following are the possible side effects that can occur during your treatment with Tafero. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.
Headache
Fever
Diarrhea
Vomiting
Nausea
Skin rash
Itching
Chills
Dizziness
Cough
Abdominal pain
Tafero (Tenofovir Alafenamide) tablet is available in the strength of 25 mg in the form of tablets for oral administration. It is a prescription medicine that helps to slow down the multiplication of the virus in the body. However, this medicine is not a permanent cure for HIV. It is advisable not to skip a dose or change the dose strength. Swallow the tablet as a whole with water, without breaking, cutting, or chewing it.
Tafero 25mg Tablet is an antiviral drug. It is a phosphonamidate prodrug of tenofovir (2’-deoxyadenosine monophosphate analog). It enters primary hepatocytes by passive diffusion and by the hepatic uptake transporters OATP1B1 and OATP1B3. It is converted to Tenofovir through hydrolysis primarily by carboxylesterase 1 (CES1) in primary hepatocytes. Tenofovir is phosphorylated by cellular kinases to the pharmacologically active metabolite Tenofovir Diphosphate. Tenofovir Diphosphate works to inhibit HBV replication through incorporation into viral DNA by the HBV reverse transcriptase, which results in DNA chain termination.
Alcohol
unsafe
Do not consume alcohol while taking Tafero.
Pregnancy
consult your doctor
Do not take Tafero without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Do not take Tafero if you're breastfeeding. Consultation of the doctor is advised.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of Tafero.
Kidney
precaution
Do not take Tafero without a doctor's consultation in case of kidney problems.
Liver
precaution
Share your medical history with the doctor in case of liver disease before taking Tafero.
It is advisable to not skip a dose. If you miss a dose, make sure to take it as soon as you remember. However, if it is already time for your next scheduled dose, skip the missed dose and take the scheduled dose. Also, make sure to not increase the dose strength to catch up with the missed dose.
Tafero 25mg Tablet is a prescription medicine. It is used in the treatment of HIV (Human Immunodeficiency Virus) infection and chronic Hepatitis B Virus (HBV) infection.
Tafero (Tenofovir Alafenamide) tablet is available in the strength of 25mg.
Take this medicine exactly as prescribed by the healthcare provider for better efficacy without increasing or decreasing the dose strength. Swallow the tablet as a whole with water, without breaking, cutting, or chewing it.
The side effects of Tafero 25mg Tablet are headache, fever, diarrhea, vomiting, nausea, skin rash, itching, etc. There can also be other side effects. Make sure to consult your healthcare provider if side effects occur or last longer than usual.
Avoid the consumption of alcohol.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre‑exposure prophylaxis (DISCOVER): Primary results from a randomised, double‑blind, multicentre, active‑controlled, phase 3, non‑inferiority trial. (2020). Lancet HIV, 7(10), e666–e676. Reddit+15PubMed+15ScienceDirect+15
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine for treatment of HIV‑1 infection in virologically suppressed adults: A randomised, double‑blind, active‑controlled, phase 3 trial. (2016). Lancet HIV, 3(11), e536–e543.
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV‑1 pre‑exposure prophylaxis: Week 96 results from a randomised, double‑blind, placebo‑controlled, phase 3 trial. (2021). Lancet HIV, 8(12), e734. PubMed
Safety and pharmacokinetics of a tenofovir alafenamide fumarate–emtricitabine based oral antiretroviral regimen for prevention of HIV acquisition in women: A randomized controlled trial. (2021). Clinical Infectious Diseases. PubMed+1PMC+1
Hetero Healthcare Limited
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.